These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2914408

  • 1. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients.
    Ono K.
    Clin Nephrol; 1989 Jan; 31(1):31-4. PubMed ID: 2914408
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F, Floridi AG, Floridi A, Buoncristiani U.
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Low total vitamin C plasma level is a risk factor for cardiovascular morbidity and mortality in hemodialysis patients.
    Deicher R, Ziai F, Bieglmayer C, Schillinger M, Hörl WH.
    J Am Soc Nephrol; 2005 Jun; 16(6):1811-8. PubMed ID: 15814831
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis.
    Hultqvist M, Hegbrant J, Nilsson-Thorell C, Lindholm T, Nilsson P, Lindén T, Hultqvist-Bengtsson U.
    Clin Nephrol; 1997 Jan; 47(1):37-46. PubMed ID: 9021240
    [Abstract] [Full Text] [Related]

  • 10. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial.
    Giancaspro V, Nuzziello M, Pallotta G, Sacchetti A, Petrarulo F.
    J Nephrol; 2000 Jan; 13(6):444-9. PubMed ID: 11132761
    [Abstract] [Full Text] [Related]

  • 11. Vitamin C status of patients with chronic renal failure, dialysis patients and patients after renal transplantation.
    Böhm V, Tiroke K, Schneider S, Sperschneider H, Stein G, Bitsch R.
    Int J Vitam Nutr Res; 1997 Jan; 67(4):262-6. PubMed ID: 9285256
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Lipoprotein oxidation profile in end stage renal disease patients. Role of vitamin C supplementation].
    Ramos R, Gómez-Geriqué N, Martínez-Castelao A.
    Nefrologia; 2005 Jan; 25(2):178-84. PubMed ID: 15912655
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lipoperoxidation and hemodialysis.
    Ramos R, Martínez-Castelao A.
    Metabolism; 2008 Oct; 57(10):1369-74. PubMed ID: 18803940
    [Abstract] [Full Text] [Related]

  • 17. Vitamins and quality of life in hemodialysis patients.
    Mydlik M, Derzsiová K.
    J Nephrol; 2008 Oct; 21 Suppl 13():S129-33. PubMed ID: 18446746
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The effects of zinc supplementation on serum zinc and cholesterol concentrations in hemodialysis patients.
    Chevalier CA, Liepa G, Murphy MD, Suneson J, Vanbeber AD, Gorman MA, Cochran C.
    J Ren Nutr; 2002 Jul; 12(3):183-9. PubMed ID: 12105816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.